KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+25.3%
5Y CAGR+30.4%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+25.3%/yr
vs +24.6%/yr prior
5Y CAGR
+30.4%/yr
Recent deceleration
Acceleration
+0.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $218.15M | +16.0% |
| 2025 | $188.00M | +33.9% |
| 2024 | $140.44M | +26.7% |
| 2023 | $110.87M | +14.8% |
| 2022 | $96.61M | +66.8% |
| 2021 | $57.92M | +8.8% |
| 2020 | $53.22M | +15.8% |
| 2019 | $45.95M | +69.6% |
| 2018 | $27.10M | +13.7% |
| 2017 | $23.84M | - |